Maxwell, Lara J., Beaton, Dorcas E., Boers, Maarten, D'Agostino, Maria Antonietta, Conaghan, Philip G., Grosskleg, Shawna, Shea, Beverley J., Bingham III, Clifton O., Boonen, Annelies, Christensen, Robin, Choy, Ernest ORCID: https://orcid.org/0000-0003-4459-8609, Doria, Andrea S., Hill, Catherine L., Hofstetter, Catherine, Kroon, Féline P.B., Leung, Ying Ying, Mackie, Sarah, Meara, Alexa, Touma, Zahi, Tugwell, Peter and Wells, George A. 2021. The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2. Seminars in Arthritis and Rheumatism 51 (6) , pp. 1320-1330. 10.1016/j.semarthrit.2021.08.011 |
Preview |
PDF
- Accepted Post-Print Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (724kB) | Preview |
Abstract
Introduction OMERACT uses an evidence-based framework known as the ‘OMERACT Filter Instrument Selection Algorithm’ (OFISA) to guide decisions in the assessment of outcome measurement instruments for inclusion in a core outcome set for interventional and observational clinical trials. Methods A group of OMERACT imaging and patient-centered outcome methodologists worked with imaging outcome groups to facilitate the selection of imaging outcome measurement instruments using the OFISA approach. The lessons learned from this work influenced the evolution to Filter 2.2 and necessitated changes to OMERACT's documentation and processes. Results OMERACT has revised documentation and processes to incorporate the evolution of instrument selection to Filter 2.2. These revisions include creation of a template for detailed definitions of the target domain which is a necessary first step for instrument selection, modifications to the Summary of Measurement Properties (SOMP) table to account for sources of variability, and development of standardized reporting tables for each measurement property. Conclusions OMERACT Filter 2.2 represents additional modifications of the OMERACT guide for working groups in their rigorous assessment of measurement properties of instruments of various types, including imaging outcome measurement instruments. Enhanced reporting aims to increase the transparency of the evidence base leading to judgements for the endorsement of instruments in core outcome sets.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
Publisher: | Elsevier |
ISSN: | 0049-0172 |
Date of First Compliant Deposit: | 16 June 2022 |
Date of Acceptance: | 28 August 2021 |
Last Modified: | 16 Nov 2024 00:30 |
URI: | https://orca.cardiff.ac.uk/id/eprint/150539 |
Citation Data
Cited 2 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |